G About
Genesis Therapeutics is a U.S.-based biotech company focused on de novo drug design for previously intractable protein targets. Their core technology is GEMS, a proprietary molecular AI platform integrating AI and physics-based modeling to generate highly potent and selective drug candidates. Genesis Therapeutics targets pharmaceutical companies and research institutions seeking to accelerate discovery for complex targets that have historically proven difficult to address with traditional methods.
Focus Areas
Technology Focus
generative ai drug discovery healthcare
Key People 2
- Evan Feinberg
- Ben Sklaroff
Quick Stats
- Total Raised
- $55M
- Founded
- 2019
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
Tempus AI
Chicago, United States
96%
4 shared categories
3 shared AI types
Same country
Healthcare AIGenerative AI +2
Insilico Medicine
Hong Kong, Hong Kong
93%
4 shared categories
3 shared AI types
Generative AIHealthcare AI +2
Exscientia
Oxford, United Kingdom
89%
4 shared categories
3 shared AI types
Drug DiscoveryHealthcare AI +2
Isomorphic Labs
London, United Kingdom
89%
4 shared categories
3 shared AI types
Drug DiscoveryGenerative AI +2